MedTrace Logo

Non-interventional Study to Assess the Number of People With Untreated/Unknown HBV + HDV and HCV in South-East Austria

NCT06834178 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2025-03-05

No results posted yet for this study

Summary

The HEAL-S study is a non-interventional study with retrospective data analysis. It consists of two parts. First a retrospective analysis based on nucleic acid testing (NAT) results will be performed. Two cohorts (HCV) and (HBV) will be established. Patients falling into one (or both) of the two cohorts will be invited to a prospective linkage-to-care study. In this part, patients are invited to the clinic, where the possibility of hepatitis treatment will be discussed.

Conditions

  • HBV
  • HCV
  • HDV
  • Coinfection
  • Hepatitis B Coinfection
  • Hepatitis B

Sponsors & Collaborators

  • Medical University of Graz

    collaborator OTHER

  • Vanessa Stadlbauer-Koellner, MD

    lead OTHER

Principal Investigators

  • Vanessa Stadlbauer-Köllner, Univ. Prof. Dr. · Medical University of Graz, Department of Gastroenterology and Hepatology, Medical University of Graz

  • Harald H. Kessler, Univ. Prof. Dr. · Diagnostic and Research Institute of Hygiene, Microbiology and Environmental Medicine, Medical University of Graz

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-04-30
Primary Completion
2026-10-31
Completion
2026-10-31

Countries

  • Austria

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06834178 on ClinicalTrials.gov